EUVIMEDEUVIMED entdecken
Netzwerk-MetaanalyseOpen Access · CC BY-NC 4.0

Prognostic Implications of Genotype Findings in Non-Ischaemic Dilated Cardiomyopathy: A Network Meta-Analysis

Vasileios Anastasiou, Andreas S Papazoglou, Thomas Gossios, Thomas Zegkos, Stylianos Daios, Dimitrios V Moysidis, Ourania Koutsiouroumpa, Despoina Parcharidou, Georgios Tziomalos, Sotiris Katranas, Pavlos Rouskas, Matthaios Didagelos und 5 weitere

European Journal of Heart Failure · 2024

DOI: 10.1002/ejhf.3403 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift European Journal of Heart Failure, 2024. Verfasst von Vasileios Anastasiou und 16 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Cardiology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Lamin Type A, Genotype, Connectin. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Evidence on the relative impact of diverse genetic backgrounds associated with non-ischaemic dilated cardiomyopathy (DCM) remains contradictory. This study sought to synthesize the available data regarding long-term outcomes of different gene groups in DCM. Methods and results Electronic databases were systematically screened to identify studies reporting prognostic data on pre-specified gene groups. Those included pathogenic/likely pathogenic (P/LP) variants, truncating titin variants (TTNtv), lamin A/C variants (LMNA), and desmosomal proteins. Outcomes were divided into composite adverse events (CAEs), malignant ventricular arrhythmic events (MVAEs) and heart failure events (HFEs). A total of 26 studies (n = 7255) were included in the meta-analysis and 6791 patients with genotyped DCM were analysed. Patients with P/LP variants had a higher risk for CAEs (odds ratio [OR] 2.10, 95% confidence interval [CI] 1.67–2.65), MVAEs (OR 1.86, 95% CI 1.52–2.26), and HFEs (OR 2.01, 95% CI 1.08–3.73) than genotype-negative patients. The presence of TTNtv was linked to a higher risk for CAEs (OR 1.78, 95% CI 1.20–2.63), but not MVAEs or HFEs. LMNA and desmosomal groups suffered a higher risk for CAEs, MVAEs, and HFEs compared to non-LMNA and non-desmosomal groups, respectively. When genes were indirectly compared, the presence of LMNA resulted in a more detrimental effect that TTNtv, with respect to all composite outcomes but no significant difference was found between LMNA and desmosomal genes. Desmosomal genes harboured a higher risk for MVAEs compared to TTNtv.

Conclusions

Different genetic substrates associated with DCM result in divergent natural histories. Routine utilization of genetic testing should be employed to refine risk stratification and inform therapeutic strategies in DCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, DilatedLamin Type AGenotypeConnectinHumansPrognosis

Stichwörter der Autor:innen

Desmosomal proteinsDilated cardiomyopathyLamin A/CNetwork meta‐analysisPrognosisTruncating titin

Substanzen

Lamin Type AConnectinLMNA protein, humanTTN protein, human

Autor:innen und Institutionen

  • 1st Department of Cardiology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Athens Naval Hospital, Athens, Greece.
  • 424 General Military Hospital, Thessaloniki, Greece.
  • Evidence Synthesis Methods Team, Department of Primary Education, School of Education, University of Ioannina, Ioannina, Greece.
  • Institute of Cardiovascular Medicine, University College London, London, UK.

ORCID-Profile: Vasileios Kamperidis

Zitieren

APA

Anastasiou, V., Papazoglou, A. S., Gossios, T., Zegkos, T., Daios, S., Moysidis, D. V., Koutsiouroumpa, O., Parcharidou, D., Tziomalos, G., Katranas, S., Rouskas, P., Didagelos, M., Karamitsos, T., Ziakas, A., McKenna, W. J., Kamperidis, V., & Efthimiadis, G. K. (2024). Prognostic Implications of Genotype Findings in Non-Ischaemic Dilated Cardiomyopathy: A Network Meta-Analysis. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3403

Vancouver

Anastasiou V, Papazoglou AS, Gossios T, Zegkos T, Daios S, Moysidis DV, et al. Prognostic Implications of Genotype Findings in Non-Ischaemic Dilated Cardiomyopathy: A Network Meta-Analysis. European Journal of Heart Failure. 2024. doi:10.1002/ejhf.3403

BibTeX
@article{Anastasiou2024,
  author = {Anastasiou, Vasileios and Papazoglou, Andreas S and Gossios, Thomas and Zegkos, Thomas and Daios, Stylianos and Moysidis, Dimitrios V and Koutsiouroumpa, Ourania and Parcharidou, Despoina and Tziomalos, Georgios and Katranas, Sotiris and Rouskas, Pavlos and Didagelos, Matthaios and Karamitsos, Theodoros and Ziakas, Antonios and McKenna, William J and Kamperidis, Vasileios and Efthimiadis, Georgios K},
  title = {Prognostic Implications of Genotype Findings in Non-Ischaemic Dilated Cardiomyopathy: A Network Meta-Analysis},
  journal = {European Journal of Heart Failure},
  year = {2024},
  doi = {10.1002/ejhf.3403}
}
Kostenlos starten →